Introduction
============

Pain is a major complication in patients with spinal cord injury (SCI) where conventional pharmacological, electrical, or psychological treatments provide only minor and temporary relief (Finnerup et al., [@B19]; Finnerup and Jensen, [@B18]; Widerstrom-Noga et al., [@B60]; Siddall, [@B51]; Kwon et al., [@B32]; Mann et al., [@B37]). Mechanisms involved in the establishment of SCI pain are still not fully understood due to difficulties in dissociating traumatic cascade of events occurring in the spinal cord to those arising from the dorsal root ganglia, sympathetic ganglia, and peripheral nerves (O'Brien et al., [@B45]; Bethea et al., [@B2]; Miranda et al., [@B41]; Springer et al., [@B53]; Yaksh et al., [@B63]; Saito et al., [@B49]; Bruce et al., [@B6]; Hains et al., [@B23]; Hoheisel et al., [@B26]). Furthermore, biochemical events leading to abnormal firing of spinal neurons (Mills et al., [@B40]; Yezierski et al., [@B66]), up-regulation of voltage-gated ion channels (Nashmi and Fehlings, [@B44]; Edwards et al., [@B17]; Hains et al., [@B22]), recruitment of reactive glia (Carlton et al., [@B8]), and excessive release of excitatory amino acids (excitotoxicity) in the spinal gray and white matters add to the complexity of neuropathic pain in SCI patients (Mills et al., [@B40]; Zeilig et al., [@B68]).

Excitotoxicity-induced SCI model using intraspinal injections of the AMPA- and metabotropic glutamate receptor agonist quisqualic acid (QUIS) have been described by Yezierski et al. (Yezierski et al., [@B65], [@B64]; Gorman et al., [@B21]). QUIS can produce more controlled-lesion with characteristic neuronal loss, demyelination, cavitation, glial activation, perivascular changes, breakdown of the blood-brain barrier, and inflammation, closely mimicking sequence of events observed in contusion or ischemic injured spinal cords. QUIS injured rats exhibit nociceptive behaviors for mechanical and cold allodynia and self-injurious overgrooming behaviors (Brewer and Yezierski, [@B5]; Gorman et al., [@B21]). Overgrooming behavior is thought to be mediated by dysesthetic sensations originating from the affected at-level dermatomes and/or DRGs ipsilateral to insult (Brewer et al., [@B3]), and disruption of inhibitory tone maintained by endogenous GABAergic neurons in the superficial dorsal horn (Lee et al., [@B33]). QUIS injury also up-regulates ERK1/2, TNF-α, and cytokines known to be involved in molecular events leading to development of nociception (Yu and Yezierski, [@B67]; Brewer and Nolan, [@B4]).

Loss of endogenous GABA-IR cells following QUIS or CNS/PNS injuries may play an important function in modulating nociception (Zhang et al., [@B69]; Lee et al., [@B33]), yet their role remains elusive (Polgar et al., [@B47]; Polgar and Todd, [@B48]). Chronic constriction injury in rats induce increased number of picnotic cells, hyperchromatic "dark neurons" possibly indicative of transsynaptic degeneration in the superficial spinal or medullary dorsal horn, in the superficial dorsal horn by one week post injury (Ibuki et al., [@B28]), and spared nerve injury decreases primary afferent-induced IPSCs in lamina II neurons, presumably due to the loss of GABA resulting from decreased GAD 65 expression (Moore et al., [@B42]). Such injury-induced nociceptive behaviors can be further exacerbated by pharmacologic blockade of inhibitory neurotransmission (Sugimoto et al., [@B56], [@B55]; Hama and Sagen, [@B24]). In stereological estimates from EM sections, excitotoxic neuronal cell death in the superficial dorsal horn was also observed in sciatic nerve-lesioned animals following stimulation of A fibers (Coggeshall et al., [@B11]), and cell death in the superficial dorsal horn (TUNEL labeling) has been observed following CCI and sciatic neurectomy which could be prevented by NMDA antagonists and caspase inhibitors (Azkue et al., [@B1]; Whiteside and Munglani, [@B59]; Scholz et al., [@B50]). Nerve injury-induced nociceptive behaviors can be reversed by the administration of GABA into the spinal cord (Eaton et al., [@B15]; Sokal and Chapman, [@B52]). Intrathecal administration of baclofen or muscimol, GABA receptor agonists, cause dose-dependent analgesia in animals with peripheral nerve injury (Hwang and Yaksh, [@B27]), and these effects were blocked with the administration of GABA receptor antagonist bicuculline suggesting specificity of GABA on reducing noxious sensation (Malan et al., [@B36]).

Recently, several reports showed possible therapeutic use of transplanting embryonic neural cells to control central and peripheral nociceptive behaviors. Intraspinal transplantation of mouse embryonic neural stem (ES) cells can reverse QUIS-induced formalin and mechanical nociception (Hendricks et al., [@B25]). Intraspinal and intrathecal injections of predifferentiated GABAergic embryonic ES cells (human and rodent-derived) can also reverse CCI/SNL-induced nociceptive behaviors (Mukhida et al., [@B43]; Jergova et al., [@B29]), possibly by rescuing the endogenous inhibitory neural circuitry (Vaysse et al., [@B57]). GABAergic neuronal stem cells (hSSC, hNT, and mouse ES) have been used to control pain arising from ischemic paraplegia as well as spinal hemisection-induced nociception (Marsala et al., [@B38]; Cizkova et al., [@B10]; Kim et al., [@B31]). Although it is not clear how the embryonic cells achieve anti-nociception (via local secretion of GABA or rescuing of endogenous GABAergic/inhibitory mechanisms), transplantation of predifferentiated embryonic inhibitory neurons can modulate nerve injury-induced pain. The source of embryonic stem cells also may be of importance, as forebrain-derived cells are reported to yield much higher density of GABAergic cells than spinal cord-derived cells (Watanabe et al., [@B58]).

The present study examined effects of transplanting partially differentiated GABA-immunoreactive embryonic cortical precursor cells in quisqualic acid-lesioned rat spinal cord to reverse pain behavior. First, we looked at the pre-differentiation of cultured embryonic rat cortical neurospheres into GABAergic phenotype by exposing the neurospheres to varying concentrations of FGF-2. The second part of the experiment focused on transplantation of predifferentiated GABAergic neurospheres into the spinal cord of QUIS-lesioned animals for the alleviation of central pain, indirectly measured by changes in overgrooming area. Results of these experiments show transplantation of predifferentiated GABAergic neural precursor cells (NPCs) into the spinal cord of QUIS-lesioned animals prevents or reduces overgrooming behavior. Portions of this work have been presented previously in abstract form (Lee et al., [@B34]).

Materials and Methods
=====================

Animals
-------

Male Sprague Dawley rats (220--250 g, Charles River labs) were housed in a regular light condition (12:12 light and dark cycle) with food and water *ad libitum*. All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Miami, Miller School of Medicine.

Quisqualic acid lesion
----------------------

All animals in the study received quisqualic acid lesion (QUIS, 125 mM, Sigma) at T12-L1 spinal level. QUIS was diluted in distilled water and aliquoted into 50 μl/vial and kept frozen (−20°C) until use. Animals were anesthetized using 3% isoflurane/O~2~ and a midline dorsal skin incision was made to expose the thoraco-lumbar vertebrae. Laminectomy was performed to expose the spinal T12-L1 levels. Animals were placed on a spinal stereotaxic unit (David Kopf Inc., CA, USA), and dura was cut and retracted laterally to expose the dorsal root entry zones. QUIS was injected into the dorsal horn halfway between the dorsal vein and the dorsal root entry zone using a glass micropipette attached to a Hamilton syringe (10 μl, Reno, NV, USA). Using a microinjector, three injections of 0.4 μl each of QUIS was injected into the spinal cord gray matter at a depth of 1 mm. Injections were made unilaterally and spaced out at 500 μm rostro-caudal direction (Figures [1](#F1){ref-type="fig"}B,C). Upon completion of each QUIS injection, the glass pipette was left in place for 60 s to prevent backflow. Muscle was closed to cover the injection site and the skin was closed with the wound clips.

![**Overgrooming lesions were primarily observed on at-level ipsilateral dermatomes two weeks after lesion \[(A): black arrow\]**. **(B)** A 3D model of spinal cord showing three injections of approximate 1 mm in depth from the dorsal surface needed to induce overgrooming in QUIS animals. **(C)** Characteristic loss of spinal neurons (Neu-N immunoreactivity) in the neck of dorsal horn 2 weeks after QUIS injection (white arrow). Neurons from the superficial lamina I and II are mostly spared from the excitotoxic cell death.](fphys-03-00167-g001){#F1}

Overgrooming behavior and overgrooming area measurements
--------------------------------------------------------

To measure changes in pain threshold before and after predifferentiated embryonic cell transplantation, the total skin overgrooming area of each animal was digitally photographed (Figure [1](#F1){ref-type="fig"}C) and then manually recorded by tracing the wound outline onto a semi-transparent plastic film superimposed over the overgrooming site. The outlines on the film were digitally retraced with Neurolucida (MicroBrightField Inc., Williston, VT, USA) and the total overgrooming area was obtained. For each QUIS-lesioned animal, the total overgrooming area was measured in square millimeter before transplantation (2 weeks post-lesion) and every week since transplantation for 3 weeks up until the time of perfusion.

Isolation of neural progenitor cells
------------------------------------

Embryonic cortical neural progenitor cells were isolated from E14 Sprague Dawley rats. Pregnant rats were deeply anesthetized with an overdose of nembutal (Sodium pentobarbital, Abbott, MI, USA) and a midline ventral incision was made to expose the embryos. Lateral ganglionic eminence were dissected out and placed into a 15 ml conical tube containing cold Hank's balanced salt solution (HBSS, pH 7.2; Gibco). Isolated cortical tissues were gently triturated mechanically to dissociate into single cells, resuspended and plated at low density (3.5 × 10^6^ in 7 ml of media) in N2 growth media (DMEM/F12 + N2 supplement, pH 7.2; Gibco) containing standard concentration of FGF-2 (10 ng/ml, R&D) at 37°C. Embryonic precursor cells were grown as small neurospheres and passaged by high flow rate trituration every 3--4 days to maintain initial density. The N2 growth media was changed every 2 days, and additional 6 μl FGF-2 (10 ng/ml) was added into the media in between media changing days.

*In vitro* partial differentiation of rat embryonic cortical precursor cells into GABA-immunoreactive cell type
---------------------------------------------------------------------------------------------------------------

Five to ten days old cultured neurospheres were transferred to 15 ml tubes, centrifuged at 700 RPM for 5 min at 4°C, and resuspended in N2 culture media containing either 0.1, 1, or 10 ng/ml FGF-2. Neurospheres were incubated in these media for 4--16 h. Neurospheres were then resuspended in N2 culture media with 10 ng/ml FGF-2 maintaining the initial density of approximately 0.5 × 10^6^ neurospheres/ml. Neurospheres were plated on a poly-[l]{.smallcaps}-ornithine/fibronectin (Sigma Aldrich) coated plastic plates for 1 day and fixed with 4% paraformaldehyde to quantitate the number of precursor cells differentiated into GABAergic cells *in vitro* after exposure to different concentrations of FGF-2. Fixed cells were also processed for GABA, NeuN, nestin, GFAP, MAP-2, β-III-tubulin, and BrdU immunofluorescence.

*In vitro* quantitation of GABA concentration secreted by the embryonic precursor neurospheres
----------------------------------------------------------------------------------------------

The growth media of cell culture from original harvested cells (P0) and *in vitro* differentiated neurospheres (P1) were sampled to ascertain the concentration of GABA secreted by the precursor neurosphere cells. The neurospheres were not stimulated electrically/physically in any way to induce GABA secretion. Twenty microliters of growth media from both samples were collected every day for 7 days. The passage 0 cells survived up to 4 day post harvest whereas the passage 1 neurospheres were visibly healthy even at 12 days post harvest. High-Pressure Liquid Chromatography (HPLC) was used to measure the concentration of GABA present in 20 μl growth media sample. Samples were analyzed on a chromatograph consisting of a Beckman Model 118 Solvent Module, a Beckman System Gold data system and an ESA Coulochem II electrochemical detector. A 150-mm long, 3-mm-diameter ESA C18 column was used. The mobile phase consisted of 1.5 mM sodium octane sulfonic acid, 75 mM NaH2PO4, triethylamine, and 10% acetonitrile dissolved in water at pH 3.0.

Transplantation of predifferentiated GABA-immunoreactive embryonic precursor cells or control bovine fibroblast cells in QUIS rats
----------------------------------------------------------------------------------------------------------------------------------

Only rats exhibiting overgrooming behavior 10--14 days post-QUIS lesion received cell transplantation (*n* = 34). Animals were anesthetized and laminectomy was performed to expose the spinal level where the QUIS lesion was made (T12-L1). Using glass micropipette, three injections of 4 μl each of neural progenitor cells (50,000 cell/μl, total 600,000 cells/animal) were injected into the dorsal horn, ipsilateral to QUIS lesion, at a depth of 0.5 mm to 1 mm (*n* = 27). Controls were injected with bovine fibroblast cells (*n* = 7). Glass pipette was left in place for 60 s to prevent backflow of the cells, muscle was closed to cover the injection site, and the skin was closed with wound clips. Rats were immunosuppressed by cyclosporine A (i.p., 10 mg/kg; Bedford Labs, OH, USA) from −1 day until sacrifice.

*In vitro* and spinal cord immunohistochemistry
-----------------------------------------------

Three weeks after cell transplantation, and after weekly measurements of overgrooming area, animals were anesthetized with an overdose of pentobarbital and perfused transcardially using a peristaltic pump. Animals were perfused with cold 0.9% saline followed by either cold 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.2) or 4% paraformaldehyde plus 1% glutaraldehyde in 0.1 M PB. Spinal cords were removed and post-fixed in the same fixative overnight, then placed in 30% sucrose-PB solution for cryoprotection.

Predifferentiated neurospheres (*in vitro*) and NPC-transplanted QUIS spinal cords were processed for immunohistochemical analysis. The neurospheres (5--7 days old) were fixed with cold 4% paraformaldehyde in Phosphate Buffered saline (PBS; pH 7.4), and were incubated overnight in PBS with 0.4% Triton-X 100 and 5% normal goat serum (PBS-TGS) containing the following primary antibodies: NeuN (1:300, mouse, Chemicon, MA, USA), GABA (1:200, guinea pig, Protos Inc., NY, USA), GFAP (1:200, mouse, Steinberg), nestin (1:10, mouse, rat401, Developmental Studies Hybridoma Bank, Iowa City, IA, USA), and β-III-tubulin (1:200, mouse, Chemicon, MA, USA). Depending on the double labeling schedule, cells were incubated with species-specific secondary antibodies conjugated with either AlexaFluor 488 or AlexFluor 594 (Molecular Probes, NY; 1:200 in PBS-TGS) for 2 h at room temperature. For BrdU labeling, fixed neurospheres were treated with 2N HCl for 10 min, washed in PBS and incubated in Borate solution for 10 min. After wash, cells were incubated in the blocking solution, primary and secondary antibody according to the protocol above. Some neurospheres were processed for GABA immunostaining using biotinylated secondary antibody, followed by incubation in avidin-biotin solution in PBS for 1h and using DAB as a chromogen.

Spinal cord segments thoracic 10 to lumbar 5 were cut at 30 μm using a freezing microtome (American Optical, MA, USA), rinsed in PBS, and then treated for 1 h at room temperature in PBS-TGS. Sections were incubated overnight in PBS-TGS containing the following primary antibodies: NeuN, GABA, GFAP, nestin, and β-III-tubulin as described above. Spinal sections were washed 3 × 10 min in cold PBS-TGS and incubated with species-specific secondary antibodies conjugated with either AlexaFluor 488 or AlexFluor 594 for 2 h at room temperature. Some spinal sections perfused with 4% paraformaldehyde-1% glutaraldehyde were treated with 1% sodium borohydride in PBS (pH 7.4) for 20 min at room temperature to mitigate background fluorescence. These sections were treated with PBS-TGS as above, and incubated overnight at 4°C in PBS-TGS containing combinations of the following primary antibodies: anti-GABA (1:500, guinea pig, Chemicon, MA, USA), anti-glycine (1:300, rabbit, Chemicon), anti-vesicular inhibitory amino acid transporter (VIAAT; 1:200, rabbit, gift from Dr. Bruno Gasnier, INSERM, Strasbourg-Cedex, France), and anti-synaptobrevin (1:1000, mouse, Synaptic Systems, Gottingen, Germany). Sections were washed 3 × 10 min in cold PBS-TGS, incubated at room temperature for 1 h in secondary antibodies: anti-guinea pig Alexa Fluor 488, anti-rabbit Alexa Fluor 594, and anti-mouse Alexa Fluor 680. All fluorescently labeled sections were washed three times in PBS, mounted on lysine-coated slides, air-dried and coverslipped using Vectashield mounting media containing DAPI (Vector Lab, CA, USA).

Microscope and image capturing
------------------------------

The majority of fluorescent sections were visualized with an Olympus fluorescent microscope. Images were acquired with a color CCD camera and ImagePro plus software (Media cybernetics Inc., Silver Spring, MD, USA) on an Apple Macintosh computer. Glutaraldehyde-treated, double- and triple-labeled sections were imaged on a Carl Zeiss LSM 510 confocal microscopy setup. An Axiovert 100M microscope with a motorized stage was operated using a PC running Zeiss LSM software version 3.2. Fluorescence was excited using Argon (514 nm) and HeNe (543, 633 nm) lasers (Lasos Lasertechnik; Jena, Germany). Images stacks were acquired with 10× dry and 40× oil immersion magnification (4 and 43 optical slices, respectively), and flattened into planar images. Adobe Photoshop was used as a digital layout tool for composition and overlay of acquired images.

Stereological analysis
----------------------

For the estimation of GABAergic and NeuN positive profiles within the transplant area in QUIS-injected animals, serial immunostained sections of lumbar spinal cord were analyzed with Neurolucida (MicroBrightField Inc., Williston, VT, USA). The transplant site was identified under 20× magnifications. Cells were counted within 0.015 mm^2^ frame positioned over the transplant area at 60× magnification. Stereological estimation was performed in 25--30 sections/spinal cord. Results are presented at average ± SEM.

Statistical analysis
--------------------

To analyze the overgrooming area of animals transplanted with control fibroblast cells and GABAergic precursor cells, the data were analyzed by two-way ANOVA with repetitive measurements with group and time post-transplantation as variables followed by Holm--Sidak *post hoc* analysis; level of significance was *p* \< 0.05.

Results
=======

Approximately 30% of animals that received quisqualic acid lesion in the spinal cord but did not display overgrooming behavior within two weeks post injury were discarded from the study. In general, overgrooming behavior was confined to ipsilateral at-level dermatomes, but a few animals displayed bilateral overgrooming behavior (Figure [1](#F1){ref-type="fig"}A).

Spinal cord histology following QUIS lesion
-------------------------------------------

In the present experiment, micro-injections of 1.2 μl of QUIS (total volume; 125 mM) at a depth of 1 mm from the dorsal surface of the spinal cord (Figure [1](#F1){ref-type="fig"}B) was sufficient to eliminate ipsilateral spinal neurons at the neck of the dorsal horn from laminae III to V/VI (Figure [1](#F1){ref-type="fig"}C). The lesion caused collapse of the gray matter into a thin dorso-ventral neuropil. Most neurons in the superficial laminae I and II, however, were spared from the injury even 3 weeks after QUIS lesion and a large number of NeuN-immunoreactive (NeuN-IR) cells were observed with a minimal gray matter disruption as previously reported (Lee et al., [@B33]). In almost all cases, neuronal cell losses were confined only to the dorsal gray matter ipsilateral to lesion. In a few animals, there were cell losses in the ipsilateral ventral horn and to the contralateral gray matter due to the spread of QUIS across the central canal, and in some instances, small cavitations in the spinal cord were observed in the ipsilateral lesioned gray matter (Yezierski et al., [@B65]). These cases were minor and may have been due to the age/weight of animal or proximal to medial placement of the glass pipette tip at the time of QUIS lesion.

Changes in GABA, glycine, and VIAAT following QUIS lesion
---------------------------------------------------------

Two weeks after QUIS lesion, there appeared substantially fewer number of endogenous GABA-IR in the superficial laminae I and II (Figure [2](#F2){ref-type="fig"}B) as described previously (Lee et al., [@B33]). Such a loss was specific to spinal level within the QUIS injury, since endogenous GABA-IR in the contralateral side and spinal levels outside the QUIS lesion area were not affected (Figure [2](#F2){ref-type="fig"}A). Immunostaining for a broader panel of markers for inhibitory neuronal signaling machinery revealed additional injury-induced histological changes. The other major spinal cord inhibitory neurotransmitter, glycine, was decreased in injured gray matter and in spared superficial laminae (Figure [2](#F2){ref-type="fig"}D), but remained unchanged in the contralateral side (Figure [2](#F2){ref-type="fig"}C).

![**Decreased immunoreactivity for inhibitory signaling components in injured spinal cord gray matter**. Spinal cord sections were stained for GABA **(A,B)** and glycine **(C,D)**. Uninjured dorsal horns showed robust staining for both neurotransmitters **(A,C)**, but staining was decreased in injured dorsal horns **(B,D)**. Spinal cord sections were also triple-stained for GABA, VIAAT, and synaptobrevin. A region within the uninjured dorsal horn was enlarged **(E)**, showing extensive VIAAT labeling (arrowheads), few lone GABA puncta (arrows), and numerous triple-labeled white puncta (block arrows). Enlargement of injured dorsal horn **(F)** revealed substantially decreased VIAAT, abundant free GABA, and few triple-labeled puncta. Scale bars = 200 μm **(D)**; 50 μm **(F)**.](fphys-03-00167-g002){#F2}

Immunostaining for synaptobrevin was used to mark synaptic vesicles in the spinal cord. Colocalization of synaptobrevin, GABA, and VIAAT was detected in spinal cord dorsal horns as white punctate staining (Figures [2](#F2){ref-type="fig"}E--F). Triple-labeled puncta were abundant in dorsal horns contralateral to QUIS injection, particularly in superficial laminae (Figure [2](#F2){ref-type="fig"}E). QUIS-injected dorsal horns appear to exhibit reduced triple labeling of inhibitory synaptic vesicle markers (Figure [2](#F2){ref-type="fig"}F). The VIAAT-IR was abundant in gray matter contralateral to QUIS injection (Figure [2](#F2){ref-type="fig"}E) but substantially decreased in the ipsilateral dorsal horn after QUIS (Figure [2](#F2){ref-type="fig"}F) which suggest that inhibitory synaptic vesicles may be depleted in the injured dorsal horn.

Time course of changes in GABA immunoreactivity from isolated embryonic cortical precursor cells
------------------------------------------------------------------------------------------------

Under standard growth condition with constant 10 ng/ml FGF-2/N2 culture media, the proportion of GABA-IR cells found in freshly isolated primary cortical embryonic tissues was minimal (P0). Presence of low number of GABA-IR cells at this growth stage correlated with the *in vitro* GABA HPLC data (see below).

In order to promote and increase the proportion of cultured cortical precursor cells to differentiate *in vitro* into GABAergic phenotype, 5--10 days post-isolation neurospheres were exposed to 0.1 ng/ml (low), 1 ng/ml (mid), or 10 ng/ml (standard concentration) of FGF-2 for 4--16 h (Figure [3](#F3){ref-type="fig"}). GABA-IR cells were observed in all three conditions, and there were minimal difference between 4 and 16 h exposure in increasing the number of GABA-IR cells. Neurospheres exposed to 0.1 ng/ml FGF-2 contained the highest number of mature-looking GABA-IR cells (Figures [3](#F3){ref-type="fig"}A,B,D). The inhibitory interneurons were mostly found inside neurospheres tightly packed as a cluster composed almost entirely of GABA-IR cells. Individual GABA-IR neuron possessed small and large processes extending radially around and out from the neurosphere. Axonal bouton enlargements were observed in processes of some cells. Neurospheres exposed to 1 and 10 ng/ml FGF-2 did not contain as many GABA-IR cells within the neurospheres as the previous group. In these groups, most of the GABA-IR cells were observed outside the neurospheres, as a single cell, in a migratory pattern dispersing radially outward from the core of neurospheres. These cells possessed short bipolar or multipolar outgrowths from the soma (Figures [3](#F3){ref-type="fig"}C,D). The predifferentiated neurospheres contained numerous dividing cells indicated by presence of BrdU-IR (Figure [3](#F3){ref-type="fig"}E). At this stage none of GABA-IR NPCs colocalized with BrdU-IR, suggesting that these are pre-existing GABA cells.

![**Brief exposure to varying concentrations of FGF-2 induces differentiation of embryonic cortical progenitor cells into GABAergic phenotype in cultured neurospheres**. Progenitor cells exposed to low concentration of FGF-2 expressed the largest number of GABA-IR cell **(A,B)**. Majority of these cells were found in or adjacent to the neurospheres and did not show migratory pattern. Progenitor cells exposed to 1 or 10 ng/ml FGF-2 did not display as many GABA-IR cells as those exposed to 0.1 ng/ml. These GABA-IR cells were found predominantly outside the neurospheres radiating outwardly in a migratory pattern **(C,D)**. Large proportion of NPCs can be labeled with BrdU, however, the GABA-IR cells did not co-label with BrdU **(E)**. A high magnification light microscopy image of GABA-IR cells inside a neurosphere labeled with DAB peroxidase reaction **(F)**. Scale bars = 20μm **(A)**; 50μm **(B--E)**.](fphys-03-00167-g003){#F3}

*In vitro* analysis of FGF-2 predifferentiated neurospheres
-----------------------------------------------------------

Several markers for mature and immature cell types were used to identify different phenotypes present in the predifferentiated neurospheres (Figure [4](#F4){ref-type="fig"}). A large proportion of NPCs expressed GAD65/67-IR where a subpopulation of them also expressed GABA-IR (Figure [4](#F4){ref-type="fig"}A). Many of GAD65/67-IR NPCs also colocalized with NeuN-IR (Figure [4](#F4){ref-type="fig"}B). Most of the embryonic progenitor cells labeled positive for nestin-IR irrespective of FGF-2 pre-differentiation conditions (Figure [4](#F4){ref-type="fig"}C). These NPCs possessed long elongated bipolar projections without any fine dendritic branches coming off from main projections. Large proportions of nestin-IR cells were positively double labeled with GABA (Figure [4](#F4){ref-type="fig"}C), but only a very small subset of GABA-IR NPCs positively colocalized with NeuN (Figure [4](#F4){ref-type="fig"}D), indicating presence of immature GABAergic NPCs in the neurospheres. Beta-III-tubulin-IR was observed in the NPCs, but only very small number of them coexpressed GABA-IR (Figure [4](#F4){ref-type="fig"}E). Many GABA-IR NPCs colocalized with MAP-2, a marker for neural maturation (Figure [4](#F4){ref-type="fig"}F). GFAP-IR was almost not present in the neurospheres (data not shown).

![**Predifferentiated embryonic precursor neurospheres expressed robust immunoreactivity for GABA and other marker for cell differentiation 5--7 days after harvest**. **(A)** Many of GABA-IR NPCs colocalized with GAD65/67-IR cells (arrows). **(B)** Majority of predifferentiated GAD65/67-IR NPCs also expressed NeuN-IR. **(C)** Majority of predifferentiated GABA-IR NPCs also expressed nestin-IR; Not every nestin-IR cells expressed GABA-IR. Many GABA-IR cells colocalized and expressed NeuN-IR **(D)**, β-III-tubulin-IR **(E)**, and MAP-2-IR **(F)**.](fphys-03-00167-g004){#F4}

*In vitro* quantitation of GABA release from predifferentiated embryonic precursor cells
----------------------------------------------------------------------------------------

The level of spontaneously released GABA concentration in the culture media was measured daily for 7 days using HPLC. Establishment of GABA release was critical to prove functional properties of our predifferentiated NPCs. The GABA concentrations from originally harvested (P0) and *in vitro* cultured (P1) neurospheres were measured. There were increased detectable levels of GABA present in the culture media starting from day 1until the last sample taken at day 7 post-isolation. For P0 cells, the GABA concentration in the media changed very little over time (Table [2](#T2){ref-type="table"}). Majority of P0 neurospheres did not survive more than 4 days *in vitro*. The GABA concentrations from P0 cells at day 1 and day 4 were 0.3955 and 0.5609 μM/20 μl, respectively. On the other hand, there was a dramatic increase in GABA concentration present in the media of P1 neurospheres. Their initial GABA concentration was very low (day 1 = 0.0941 μM/20 μl) but increased by 10-fold at day 7 (1.0673 μM/20 μl) suggesting massive differentiation of NPCs into GABAergic cells.

Changes in overgrooming area following transplantation of GABAergic precursor cells
-----------------------------------------------------------------------------------

Excitotoxic QUIS lesion caused a continuous and progressive damage to the spinal cord where the extent of the SCI as well as the size of peripheral overgrooming area increased progressively over time (Brewer and Yezierski, [@B5]). All of QUIS-lesioned animals that received transplantation of control cells (bovine adrenal fibroblast, *n* = 7) showed a significant increase in overgrooming area over time where the area at pretransplantation (baseline) was 130.2 ± 28.9 mm^2^ and increased by three folds to 348.1 ± 115.08 mm^2^ at 1 week post-transplantation (Figures [5](#F5){ref-type="fig"}A,C and [6](#F6){ref-type="fig"}A). By 2 and 3 weeks, the overgrooming area remained significantly enlarged to 438.5 + 121.0 and 399.0 + 120.80 mm^2^, respectively (*p* \< 0.05). On the other hand, QUIS-lesioned animals that received transplantation of predifferentiated GABA-IR NPCs (*n* = 27) did not show significant increase in overgrooming area, but remained at near baseline level during 3 weeks of the testing period (Figures [5](#F5){ref-type="fig"}B,D). In these rats, the baseline overgrooming area was 181.5 + 27.3 mm^2^, and 3 weeks after transplantation the overgrooming area remained at 237.3 ± 55.8 mm^2^ (Figure [6](#F6){ref-type="fig"}A). Overall 55.6% of animals (*n* = 15/27) displayed overgrooming areas that were either the same or smaller than at pretransplantation stage; 27% of the animals (*n* = 7/27) displayed a 50% reduction in the overgrooming area by 3 weeks post-transplantation. Seven animals completely recovered from overgrooming injuries. When the percent changes in grooming areas were compared between groups, the overgrooming areas of rats that received GABA-IR NPCs were significantly smaller than fibroblast-transplanted control rats during the experimental period (*p* \< 0.01; Figure [6](#F6){ref-type="fig"}B).

![**Photomicrographs showing changes in size of overgrooming in QUIS animals transplanted with control bovine fibroblast cells \[pretransplantation: (A) 3 weeks post: (C)\] and predifferentiated GABA-IR NPCs \[pretransplantation: (B), 3 weeks post: (D)\]**.](fphys-03-00167-g005){#F5}

![**Percent change of the overgrooming area from pretransplantation for GABA and fibroblast-transplanted rats**. Control animals displayed significant increases in total overgrooming area **(A)** and percent change of overgrooming area **(B)** post-transplantation vs. pretransplantation and also compared to GABA-transplanted animals. GABA-transplanted rats did not display statistically significant changes in either total or percent change of overgrooming compared to pretransplantation. \**p* \< 0.05 vs. pretransplantation, ^\#^*p* \< 0.05 vs. GABA group.](fphys-03-00167-g006){#F6}

Identification of GABA-IR NPCs in the spinal cord of QUIS-lesioned animals
--------------------------------------------------------------------------

Transplanted NPCs were observed within the spinal level of QUIS-lesioned sites. The immunohistochemical analysis revealed the NPCs were placed adjacent to the midline encompassing the medial aspect of spinal gray matter and the dorsal column (Figure [7](#F7){ref-type="fig"}). Surviving GABA-IR NPCs were observed covering a large extent of the dorsal horn from Rexed's lamina I--VI and as medial as the dorsal column. Based on our previous study (Furmanski et al., [@B20]), the grafted cells were distinguished from endogenous GABAergic interneurons by their different morphology and location in the spinal cord. Grafted NPCs appeared as large and round cells in superficial and deeper dorsal horn laminae in contrast to much smaller and elongated endogenous interneurons located mainly in superficial laminae. Overall, the spinal cords could be divided into three groups: those containing (i) large, (ii) moderate, or (iii) minimal number of GABA-IR NPCs in the dorsal gray matter. The number of surviving GABA-IR NPCs inversely correlated with the size of overgrooming area. Animals with large number of GABA-IR NPCs in the spinal cord displayed the smallest to no overgrooming lesion area. Animals containing medium to low number of GABA-IR NPCs displayed same or increased overgrooming area compared to pretransplantation state.

![**Transplanted predifferentiated GABA-IR NPCs were visible in the spinal cord of QUIS animals three weeks after transplantation, and showed varying densities in the host spinal cord**. Animals that stopped overgrooming \[healed; **(A,B)**\] or displayed reduction in overgrooming **(C,D)** exhibited large number of transplanted GABA-IR NPCs in the spinal gray matter. Animals that continued to groom contained very few number of surviving GABA-IR cells in the spinal cord **(E,F)**. Scale bars = 500 μm.](fphys-03-00167-g007){#F7}

Overall, the spinal cords could be divided into three groups: those containing (i) large, (ii) moderate, or (iii) minimal number of GABA-IR NPCs in the dorsal gray matter. The number of surviving GABA-IR NPCs inversely correlated with the size of overgrooming area. Animals with large number of GABA-IR NPCs in the spinal cord displayed the smallest to no overgrooming lesion area. Animals containing medium to low number of GABA-IR NPCs displayed same or increased overgrooming area compared to pretransplantation state.

*In vivo* differentiation of embryonic GABA-IR NPCs
---------------------------------------------------

Surviving NPCs within the injured spinal cord exhibited immunoreactivity for GABA and several other cell markers. The GABA-IR cells ranged in size of a small interneuron to a large spinal motor neuron (Figure [8](#F8){ref-type="fig"} left two columns). The GABA-IR cells double labeled with neuronal marker, NeuN (Figures [8](#F8){ref-type="fig"}A--D), but did not express nestin-IR indicating differentiation into mature neurons. Although GFAP- and β-III-tubulin-IR were present within the transplantation site of NPCs, neither of them colocalized with GABA-IR (Figures [8](#F8){ref-type="fig"}I--P).

![**Photomicrographs of QUIS spinal cord transplanted with GABA-IR NPCs**. The NPCs were double labeled with NeuN **(A--D)**, nestin **(E--H)**, GFAP **(I--L)**, and β-III-tubulin **(M--P)**. Medium **(A,E,I,M)** and high magnification **(B,F,J,N)** of QUIS spinal cord stained for GABA-IR NPCs. The dotted lines represent the spinal gray matter, and white boxes represent the ROI in panels **(B,F,J,N)**. Majority of GABA-IR NPCs double labeled with NeuN-IR **(B--D)**. However, the GABA-IR NPCs did not colocalize with nestin **(F--H)**, GFAP **(J--L)**, or with β-III-tubulin **(N--P)**.](fphys-03-00167-g008){#F8}

Stereological quantitation of GABA-IR cells in the QUIS spinal cord
-------------------------------------------------------------------

Stereological evaluation was performed on spinal cord sections from these animals in a tissue volume of 0.7 ± 0.04 mm^3^. About 30--40% of surviving predifferentiated GABA-IR cells colocalized with NeuN indicating maturity to neuronal phenotype (Table [1](#T1){ref-type="table"}). The majority of GABA-IR cells (67.8 ± 2.7%) within the transplant area did not colocalize with NeuN indicating immaturity 3 weeks post-transplantation into host spinal cord. Similar numbers were obtained when sections were processed for GAD65/67 (data not shown).

###### 

**Stereological quantitation of predifferentiated GABAergic precursor cells following intraspinal transplantation of QUIS animals**.

  ID    GABA only (single)   GABA + NeuN (double)   GABA total   \% of GABA only   \% of GABA + NeuN   Total counting area (μm^2^)   Total volume (mm^3^)
  ----- -------------------- ---------------------- ------------ ----------------- ------------------- ----------------------------- ----------------------
  Q12   606                  401                    1007         60                40                  4350                          0.74
  Q16   952                  422                    1374         69                31                  3600                          0.61
  Q24   314                  137                    451          70                30                  3600                          0.61
  Q26   536                  204                    740          72                28                  4350                          0.74

Discussion
==========

Results from the present study show that intraspinal transplantation of predifferentiated embryonic GABAergic NPCs, but not bovine fibroblast cells, significantly decreases self-injurious overgrooming lesions observed in QUIS injured rats. The decrease in overgrooming may be mediated by the GABA released from the transplanted precursor cells since the reduction in grooming was observed primarily GABA-transplated QUIS animals. Manifestation of overgrooming behavior is thought to have a relation with dysesthetic and nociceptive sensations since subdural transplantation of analgesic compound-releasing chromaffin cells can reverse mechanical and thermal nociceptive thresholds in QUIS rats, in addition to significant reduction on the size of overgrooming area by 2 weeks post-transplantation compared to muscle transplanted control rats (Brewer and Yezierski, [@B5]).

In our experiment, reversal of overgrooming lesion was observed in 55.6% (*n* = 15/27) of GABA-transplanted rats from which seven rats recovered completely from self-inflicted dermal injuries 3 weeks post-transplantation. The main contributing factor for these recoveries may be the secretion of GABA in the lesioned dorsal horn by the embryonic GABA-IR NPCs transplanted into the host spinal cord, since fibroblast-transplanted control rats (*n* = 7) or QUIS animals with only a small number of surviving transplanted GABA cells did not show a decrease in their overgrooming lesion. In fact, the latter group of animals showed increasing overgrooming lesion size overtime closely resembling the pattern observed in fibroblast-transplanted control rats. The results from our experiment show intraspinal transplantation of GABA secreting embryonic precursor cells are effective in reducing centrally- and peripherally mediated nociceptive behaviors without causing sensory and motor deficits, similar to observations reported by others (Hendricks et al., [@B25]; Mukhida et al., [@B43]; Wolfe et al., [@B62]).

Changes in the number and expression of endogenous GABA leading to abnormal inhibitory signaling following spinal or peripheral nerve injuries have been well documented in several rodents pain models, yet their role in expression of nociceptive behaviors remain divided (Polgar et al., [@B47]; Lee et al., [@B33]; Polgar and Todd, [@B48]; Meisner et al., [@B39]). The postulated loss of GABAergic neurons is controversial, however, as a reduction in GABAergic immunoreactivity in parallel with the development of neuropathic pain symptoms is not always observed (Polgar et al., [@B47], [@B46]; Polgar and Todd, [@B48]). Nevertheless, alternative explanations for disinhibition after nerve injury include reduced GABA synthesis in existing intact, but dysfunctional neurons or reduced excitatory drive to GABAergic dorsal horn neurons following loss of primary afferent input to these cells. Alterations in GABA receptors, e.g., loss of receptors or reversion to a neonatal excitatory and pronociceptive GABA phenotype may also occur. Diminished GABAergic inhibitory effects via reduced expression of the potassium co-transporter KCC-2 and disruption of the chloride gradient has been suggested as an underlying mechanism of activated microglia in neuropathic pain induction (Coull et al., [@B13], [@B12]). However, pharmacologic findings argue against a complete excitatory reversion since GABA and GABAergic agonists can reduce neuropathic pain behaviors. In addition, electrophysiological studies suggest that diminished GABA release, rather than changes in receptor density, account for the loss in GABAergic inhibition in peripheral nerve injury models (Moore et al., [@B42]). Regardless whether or not overt GABAergic cellular death occurs, it is clear that loss of spinal inhibitory tone and consequent abnormal hyperexcitability contribute to the maintenance of neuropathic pain, and is a promising target for intervention.

Previously, our group reported selective loss of endogenous GABA-IR cells following excitotoxic QUIS lesion in rats (Lee et al., [@B33]), similar to the previously mentioned animal pain/nociceptive models that reported loss of GABAergic cells. It is not clear whether the decrease of GABA-labeled cells is due to apoptosis, down-regulation of GAD genes, or another mechanism. Spinal contusion injury-induced secretion of excitatory amino acids and subsequent activation of metabotropic glutamate receptors (mGluRs) has been shown to increase the GABA concentration in the spinal cord by 160% (4.8 μM) within half an hour of injury (Mills et al., [@B40]). Blocking mGluR1/5 with antagonist agents (10 nM AIDA, LY 367385 + MPEP) can prevent GABA release. It is possible that excessive mGluR1/5 activity after SCI could contribute to depletion of cellular GABA stores, indicated by decreased GABA immunoreactivity. We also provide evidence that glycine is reduced similar to GABA in the injured dorsal horn. Since GABA and glycine are frequently co-released at synapses, in part due to the shared vesicular transporter VIAAT (Wojcik et al., [@B61]; Juge et al., [@B30]), excessive mGluR1/5 activity could contribute to depletion of glycine stores as well.

The VIAAT loads GABA and glycine into presynaptic vesicles at inhibitory synapses (Dumoulin et al., [@B14]). In the current experiments, we found that VIAAT-IR was decreased in the QUIS-lesioned dorsal horn. Furthermore, colocalization of GABA, VIAAT, and the synaptic protein synaptobrevin was substantially decreased in the injured dorsal horn. An injury-induced decrease in VIAAT expression could lead to an inability to load available GABA into presynaptic vesicles, which could be reflected by increased free GABA-IR in the injured dorsal horn. Another possible mechanism is that QUIS-induced cell death in the dorsal horn deprives inhibitory neurons of their targets, causing axonal retraction, and decreased axonal trafficking of inhibitory vesicles. Alone or in combination, these potential causes of decreased inhibitory synaptic communication could operate in concert with previously described mechanisms of spinal cord hyperexcitability that are associated with injury-induced chronic pain.

Embryonic stem and precursor cells can be grown in culture and, depending on growth factors, can be induced to differentiate into many different cell types. In this study, we explored ways to promote and increase the number of cultured cortical precursor cells to differentiate *in vitro* into GABAergic phenotype by varying the concentration level of FGF-2 present in the growth media. Cells grown under standard concentration of FGF-2 then switched to low concentration (0.1 ng/ml) for several hours facilitated transformation to GABAergic phenotype. The molecular biochemistry underlying such transformation remains unclear. It is important to note that not all phenotypic GABA cells colocalized with the neuronal marker NeuN. The vast majority of GABAergic cells colocalized with β-III-tubulin and MAP-2 suggesting incomplete neuronal differentiation 24--36 h after FGF-2 removal.

In addition to GABA, the vast majority of NPCs in these cultures were nestin-IR, indicating they were undifferentiated progenitor cells. All GABA-positive cells were double labeled with nestin. But no GABA cells colocalized with GFAP-IR cells indicating that most of our GABA cells were still in immature state and GABA was not present in the astrocytes. The majority of GABA cells were found as a cluster inside the neurospheres, suggesting they are clonally derived. Functional biochemical properties of our GABAergic neurospheres were demonstrated by high-pressure liquid chromatography (HPLC) where the secreted/released concentration of GABA in the culture media increased 10-fold to 1 μM/20 μl culture media over a 7-day period *in vitro* (Table [2](#T2){ref-type="table"}). We were not able to obtain *in vitro* GABA HPLC data for P0 cells beyond 4 days due to decreased representation of GABA neurons in the culture with time (data not shown). Only the P0 precursor cells proliferate in the N2 culture media while the P0 GABA cells do not. Therefore in the non-proliferating P0 GABA cells that are already differentiated cells become a negligible fraction by day 4. In contrast the large numbers of P1 precursors differentiate into GABAergic cells persist longer in the culture in the absence of any cell proliferation. These data demonstrate that brief exposure of embryonic cortical precursor cells to low concentration of FGF-2 stimulates GABAergic cell differentiation, but that the differentiation status remains largely incomplete.

###### 

**Non-stimulation-induced released GABA concentration in the N2 growth media over time for P0 and P1 embryonic precursor cells (μM/20 μl)**.

              Day 1    Day 2    Day 3    Day 4    Day 5    Day 6    Day 7
  ----------- -------- -------- -------- -------- -------- -------- --------
  Passage 0   0.3955   0.3187   0.3844   0.5609   N/A      N/A      N/A
  Passage 1   0.0941   0.0993   0.1540   0.2088   0.6500   0.9475   1.0673

Overgrooming behavior observed in QUIS rats is thought to have a nociceptive component in its expression. Previously, subdural transplantation of chromaffin cells in the spinal cord of QUIS animals significantly decreased their overgrooming area directly demonstrating analgesic compound secreted from chromaffin cells, mainly norepinephrine, can reduce the overgrooming behavior (Brewer and Yezierski, [@B5]). In the present experiment, intraspinal transplantation of predifferentiated embryonic GABAergic cells also significantly decreased the overgrooming area at all-time points studied compared to fibroblast-transplanted control QUIS rats. The main factor for such an effect was most likely the absence of GABA cells since QUIS animals with very few surviving GABA cells also showed increased overgrooming. We know from past reports that only about 5--10% of transplants survive following incorporation to the host CNS (Chow et al., [@B9]; Cao et al., [@B7]; Hendricks et al., [@B25]; Lepore et al., [@B35]) but this number is sufficient for producing a significant effect on host behavior. Our recent paper (Jergova et al., [@B29]) shows that intraspinal injection of GABAergic progenitors partially restore inhibitory tone in the spinal cord in CCI model. Behavioral and electrophysiological experiments showed that the analgesic effect of grafted cell is positively or negatively modulated by GABA reuptake inhibitor or GABA receptor antagonist respectively.

In present study, quantitation of surviving GABAergic cells from select tissues showed that over 67% of transplanted cells remained as incompletely differentiated GABAergic cells. However, about 40% of predifferentiated cells displayed neuronal phenotypes positive for NeuN immunoreactivity.

Several reports exist that describe transplantations of predifferentiated GABAergic and non-GABAergic embryonic precursor cells to alleviate peripheral and central neuropathic pain (Eaton et al., [@B16]; Stubley et al., [@B54]; Hendricks et al., [@B25]; Mukhida et al., [@B43]; Jergova et al., [@B29]). However, the present study is first to describe the effect of predifferentiated embryonic GABAergic cells transplanted in SCI animals to reverse dysesthetic/nociceptive behaviors.

In summary, the current study suggests transplantation of predifferentiated embryonic GABAergic cells in QUIS-lesioned rats can greatly reduce the overgrooming lesion size. Such reduction may be mediated with the release of GABA from the transplants. GABA replacement therapy through cell transplantation could be used to offset losses of inhibitory signaling molecules in injured spinal cord gray matter. The reversal of overgrooming behavior was associated with the density of surviving GABA-IR transplants in the injured host spinal cord.
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